Esperion Therapeutics
ESPR
#6586
Rank
S$1.05 B
Marketcap
S$4.09
Share price
-0.31%
Change (1 day)
226.94%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): S-$0.66

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.65. In 2024 the company made an earnings per share (EPS) of S-$0.30 an increase over its 2023 EPS that were of S-$2.74.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.66122.99%
2024S-$0.30-89.15%
2023S-$2.74-40.28%
2022S-$4.59-62.87%
2021S-$12.3780.38%
2020S-$6.8650.14%
2019S-$4.57-53.18%
2018S-$9.757.41%
2017S-$9.08110.81%
2016S-$4.3147.35%
2015S-$2.920.89%
2014S-$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.69-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$55.02-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.90 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.25-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.81-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA